Levine Alan M 4/A
4/A · Axogen, Inc. · Filed Jun 12, 2020
Insider Transaction Report
Form 4/AAmended
Axogen, Inc.AXGN
Levine Alan M
Director
Transactions
- Award
Stock Option (right to purchase)
2020-06-01+12,605→ 12,605 totalExercise: $9.72Exp: 2030-06-01→ Common Stock (12,605 underlying) - Award
Restricted Stock Units
2020-06-01+6,173→ 6,173 total→ Common Stock (6,173 underlying)
Footnotes (3)
- [F1]Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2021, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F3]The original Form 4 filed on June 3, 2020, is a duplicate filing. The updated beneficial holdings are being submitted in this Form 4/A.